Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 3/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.49 |
| ▸ | THRA | P10827 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 1/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CNR1 | P21554 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15848185 | 1.00 | EPHX2 (0.50) | EPHX2THRBTHRAMGLLFAAH | |
| SCHEMBL15847974 | 1.00 | EPHX2 (0.50) | EPHX2THRBTHRAMGLLFAAH | |
| SCHEMBL15848199 | 1.00 | EPHX2 (0.50) | EPHX2THRBTHRAMGLLFAAH | |
| SCHEMBL15848183 | 1.00 | EPHX2 (0.50) | EPHX2THRBTHRAMGLLFAAH | |
| SCHEMBL15847993 | 1.00 | EPHX2 (0.50) | EPHX2THRBTHRAMGLLFAAH | |
| SCHEMBL15848517 | 0.93 | THRB (0.55) | THRBTHRADGKA | |
| SCHEMBL15848363 | 0.93 | THRB (0.55) | THRBTHRADGKA | |
| SCHEMBL15848329 | 0.93 | THRB (0.55) | THRBTHRADGKA | |
| SCHEMBL25299329 | 0.87 | EPHX2 (0.44) | EPHX2THRBTHRACNR1DGKA | |
| SCHEMBL29312860 | 0.85 | FAAH (0.51) | EPHX2THRBTHRAMGLLFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170190947-A9 | BETA-AMINO ESTER GAS HYDRATE INHIBITORS | APERGY BMCS ACQUISITION CORP | 2017-07-06 | — | — | US | claimed |
| US-20160362595-A1 | BETA-AMINO ESTER GAS HYDRATE INHIBITORS | NALCO CO (US) | 2016-12-15 | — | — | US | claimed |
| EP-2938604-B1 | BETA-AMINO ESTER GAS HYDRATE INHIBITORS | NALCO CO (US) | 2018-05-30 | — | — | EP | disclosed |
| US-20170190947-A9 | BETA-AMINO ESTER GAS HYDRATE INHIBITORS | APERGY BMCS ACQUISITION CORP | 2017-07-06 | — | — | US | disclosed |
| US-20160362595-A1 | BETA-AMINO ESTER GAS HYDRATE INHIBITORS | NALCO CO (US) | 2016-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160362595-A1 | BETA-AMINO ESTER GAS HYDRATE INHIBITORS | SLC43A1, AQP1, SLC6A12 | EPHX2 974/4885THRB 1262/4885THRA 2462/4885 |
| US-20170190947-A9 | BETA-AMINO ESTER GAS HYDRATE INHIBITORS | SLC43A1, AQP1, SLC6A12 | EPHX2 974/4885THRB 1262/4885THRA 2462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.